Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST). (2022)
Attributed to:
CANCER: Trials with potential global reach and other challenging trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1200/jco.21.01199
PubMed Identifier: 35298280
Publication URI: http://europepmc.org/abstract/MED/35298280
Type: Journal Article/Review
Volume: 40
Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Issue: 22
ISSN: 0732-183X